The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Nulman, I.
* Articles by Koren, G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Nulman, I.
* Articles by Koren, G.
Related Collections
* Child/Adolescent Psychiatry
* Gender
* Depression
* Antidepressants
* Cognition
Am J Psychiatry 159:1889-1895, November 2002
© 2002 American Psychiatric Association


Article

Child Development Following Exposure to Tricyclic Antidepressants or Fluoxetine Throughout Fetal Life: A Prospective, Controlled Study

Irena Nulman, M.D., Joanne Rovet, Ph.D., Donna E. Stewart, M.D., Jacob Wolpin, Ph.D., Pia Pace-Asciak, B.A., Samar Shuhaiber, M.Sc., and Gideon Koren, M.D.

OBJECTIVE: Previous work suggested that first-trimester exposure to tricyclic antidepressants or fluoxetine does not affect adversely child IQ and language development. However, many women need antidepressants throughout pregnancy to avoid morbidity and suicide attempts. Little is known about the fetal safety of tricyclic antidepressants and fluoxetine when taken throughout pregnancy. The goal of this study was to assess the effects of tricyclic antidepressants and fluoxetine used throughout gestation on child IQ, language, and behavior. METHOD: In a prospective study, mother-child pairs exposed throughout gestation to tricyclic antidepressants (N=46) or fluoxetine (N=40) and an unexposed, not depressed comparison group (N=36) were blindly assessed. The three groups were compared in terms of the children’s IQ, language, behavior, and temperament between ages 15 and 71 months. The authors adjusted for independent variables such as duration and severity of maternal depression, duration of pharmacological treatment, number of depression episodes after delivery, maternal IQ, socioeconomic status, cigarette smoking, and alcohol use. RESULTS: Neither tricyclic antidepressants nor fluoxetine adversely affected the child’s global IQ, language development, or behavior. IQ was significantly and negatively associated with duration of depression, whereas language was negatively associated with number of depression episodes after delivery. CONCLUSIONS: Exposure to tricyclic antidepressants or fluoxetine throughout gestation does not appear to adversely affect cognition, language development, or the temperament of preschool and early-school children. In contrast, mothers’ depression is associated with less cognitive and language achievement by their children. When needed, adequate antidepressant therapy should be instituted and maintained during pregnancy and postpartum.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
R. Suri, L. Altshuler, G. Hellemann, V. K. Burt, A. Aquino, and J. Mintz
Effects of Antenatal Depression and Antidepressant Treatment on Gestational Age at Birth and Risk of Preterm Birth
Am J Psychiatry, August 1, 2007; 164(8): 1206 - 1213.
[Abstract] [Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Antidepressants During Pregnancy: Treating the Condition While Acknowledging the Risks
Journal Watch Women's Health, April 26, 2007; 2007(426): 1 - 1.
[Full Text]


Home page
Arch Pediatr Adolesc MedHome page
T. F. Oberlander, P. Reebye, S. Misri, M. Papsdorf, J. Kim, and R. E. Grunau
Externalizing and Attentional Behaviors in Children of Depressed Mothers Treated With a Selective Serotonin Reuptake Inhibitor Antidepressant During Pregnancy
Arch Pediatr Adolesc Med, January 1, 2007; 161(1): 22 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
L. M. Bodnar, K. R. Sunder, and K. L. Wisner
Treatment With Selective Serotonin Reuptake Inhibitors During Pregnancy: Deceleration of Weight Gain Because of Depression or Drug?
Am J Psychiatry, June 1, 2006; 163(6): 986 - 991.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. Misri, P. Reebye, K. Kendrick, D. Carter, D. Ryan, R. E. Grunau, and T. F. Oberlander
Internalizing Behaviors in 4-Year-Old Children Exposed in Utero to Psychotropic Medications
Am J Psychiatry, June 1, 2006; 163(6): 1026 - 1032.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. L. Moses-Kolko, D. Bogen, J. Perel, K. L. Wisner, A. Bregar, K. Uhl, and B. Levin
Neonatal Signs After In Utero Exposure to Selective Serotonin Reuptake Inhibitors--Reply
JAMA, November 9, 2005; 294(18): 2300 - 2301.
[Full Text] [PDF]


Home page
J PsychopharmacolHome page
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
J Psychopharmacol, November 1, 2005; 19(6): 567 - 596.
[Abstract] [PDF]


Home page
EndocrinologyHome page
S. J. Warden, A. G. Robling, M. S. Sanders, M. M. Bliziotes, and C. H. Turner
Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth
Endocrinology, February 1, 2005; 146(2): 685 - 693.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. F. Oberlander, R. E. Grunau, C. Fitzgerald, M. Papsdorf, D. Rurak, and W. Riggs
Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure
Pediatrics, February 1, 2005; 115(2): 411 - 425.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. D. Norton, L. L. M. Worley, and C. L. Lowery
Findings From Selective Serotonin Reuptake Inhibitor-Exposed Neonates Should Be Interpreted With Caution
Pediatrics, December 1, 2004; 114(6): 1739 - 1740.
[Full Text] [PDF]


Home page
ScienceHome page
M. S. Ansorge, M. Zhou, A. Lira, R. Hen, and J. A. Gingrich
Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Science, October 29, 2004; 306(5697): 879 - 881.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
G. Koren
Discontinuation Syndrome Following Late Pregnancy Exposure to Antidepressants
Arch Pediatr Adolesc Med, April 1, 2004; 158(4): 307 - 308.
[Full Text] [PDF]


Home page
PediatricsHome page
P. S. Zeskind and L. E. Stephens
Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
Pediatrics, February 1, 2004; 113(2): 368 - 375.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
D. Kohen
Psychotropic medication in pregnancy
Advan. Psychiatr. Treat., January 1, 2004; 10(1): 59 - 66.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. H. GOLD
Women's Mental Health: A Comprehensive Textbook
Am J Psychiatry, July 1, 2003; 160(7): 1361 - 1361.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Better a Treated Mom Than a Depressed Mom
Journal Watch Psychiatry, February 20, 2003; 2003(220): 10 - 10.
[Full Text]


Home page
JWatch PsychiatryHome page
Antidepressants During Pregnancy: Benefits for Children
Journal Watch Psychiatry, December 19, 2002; 2002(1219): 1 - 1.
[Full Text]


Home page
JWatch Women's HealthHome page
Better a Treated Mom Than a Depressed Mom
Journal Watch Women's Health, December 17, 2002; 2002(1217): 7 - 7.
[Full Text]


Home page
Psychiatr. NewsHome page
J. Rosack

Psychiatr News, November 1, 2002; 37(21): 26 - 26.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org